Cellectis Receives New 'Buy' Rating from Clear Street, Analysts Predict 47.46% Upside

Clear Street initiates coverage on Cellectis (CLLS) with a "Buy" rating and a price target of $9.00. Barclays previously maintained an "Overweight" rating and raised the price target from $4.00 to $8.00 in October. This indicates a shifting focus on the company's potential, with an average target price of $7.17 and a high estimate of $10.00.